Founded Year



Series A | Alive

Total Raised


Last Raised

$8.72M | 2 yrs ago

About Gleamer

Gleamer is a French developer of artificial intelligence-based solutions for radiologists that provides automated diagnosis of medical images and generates a report by detecting lesions in an image and characterizing them.

Gleamer Headquarter Location

96 bis Boulevard Raspail

Paris, 75006,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Gleamer

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Gleamer in 1 CB Insights research brief, most recently on Jul 1, 2020.

Expert Collections containing Gleamer

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Gleamer is included in 5 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

8,442 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,707 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

10,939 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Latest Gleamer News

Aidoc and Gleamer’s new partnership expands the use of AI in healthcare systems

Jun 1, 2022

The market for artificial intelligence (AI) and machine learning (ML) platforms will reach $52bn in 2024, up from $29bn in 2019. The post Aidoc and Gleamer’s new partnership expands the use of AI in healthcare systems appeared first on Medical Device Network.

Gleamer Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Gleamer Rank

  • When was Gleamer founded?

    Gleamer was founded in 2017.

  • Where is Gleamer's headquarters?

    Gleamer's headquarters is located at 96 bis Boulevard Raspail, Paris.

  • What is Gleamer's latest funding round?

    Gleamer's latest funding round is Series A.

  • How much did Gleamer raise?

    Gleamer raised a total of $10.54M.

  • Who are the investors of Gleamer?

    Investors of Gleamer include XAnge, Bpifrance, Elaia Partners, MACSF, Majycc Esante Invest and 6 more.

  • Who are Gleamer's competitors?

    Competitors of Gleamer include Aidoc Medical and 5 more.

You May Also Like

Enlitic Logo

Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.

Imagen Technologies

Imagen is building a world without diagnostic errors. The company is beginning by applying the latest advances in computer vision and machine learning to medical imaging. Imagen Technologies is putting leading medical expertise in the hands of healthcare providers everywhere.

QED Technique

QED Technique is a CAD-based health platform that focuses on intelligent medical image analysis of brain, heart, lung, kidney, and thyroid, using 3D reconstruction, proprietary mathematical models, big data, and artificial intelligence to constantly improve diagnostic accuracy.

Kheiron Medical Technologies

Kheiron Medical Technologies is a healthcare software company. Through its Machine Learning technology, it seeks to makes cancer diagnoses faster, easier, cheaper and more accurate. Its Deep Learning algorithms analyze medical images and its software uses the analysis results to enable the automation of radiology reporting tasks.


12 SIGMA is a biotechnology company that integrates artificial intelligence and deep learning into modern medical image diagnosis and medical data analysis. 12SIGMA is based in Beijing and San Diego.

Infervision Logo

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.